🇺🇸 FDA
Patent

US 7807623

Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

granted A61KA61K38/2207A61P

Quick answer

US patent 7807623 (Use of pentagastrin to inhibit gastric acid secretion or as a diuretic) held by The Regents of the University of California expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/2207, A61P, A61P1/00